Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma.
Gavini J, Dommann N, Jakob MO, Keogh A, Bouchez LC, Karkampouna S, Julio MK, Medova M, Zimmer Y, Schläfli AM, Tschan MP, Candinas D, Stroka D, Banz V.
Gavini J, et al. Among authors: stroka d.
Cell Death Dis. 2019 Oct 3;10(10):749. doi: 10.1038/s41419-019-1989-z.
Cell Death Dis. 2019.
PMID: 31582741
Free PMC article.